The glycoprotein products of varicella-zoster virus gene 14 and their defective accumulation in a vaccine strain (Oka).
about
Varicella-zoster virusEpigenetic regulation of varicella-zoster virus open reading frames 62 and 63 in latently infected human trigeminal ganglia.Recombinant varicella vaccines induce neutralizing antibodies and cellular immune responses to SIV and reduce viral loads in immunized rhesus macaques.Delayed biosynthesis of varicella-zoster virus glycoprotein C: upregulation by hexamethylene bisacetamide and retinoic acid treatment of infected cells.The transcriptional regulatory proteins encoded by varicella-zoster virus open reading frames (ORFs) 4 and 63, but not ORF 61, are associated with purified virus particles.Varicella zoster virus glycoprotein C increases chemokine-mediated leukocyte migration.The varicella-zoster virus immediate-early protein IE62 is a major component of virus particles.Transcription from varicella-zoster virus gene 67 (glycoprotein IV).Neutralizing antibodies induced by recombinant vaccinia virus expressing varicella-zoster virus gpIV.Recombinant varicella-zoster virus vaccines as platforms for expression of foreign antigens.Varicella-zoster virus proteins in skin lesions: implications for a novel role of ORF29p in chickenpox.Identification of varicella-zoster virus strains by PCR analysis of three repeat elements and a PstI-site-less region.COMMENTARY: Significantly less anti-gC antibody detectable in sera collected after varicella vaccination than after the disease varicella.Discordant varicella-zoster virus glycoprotein C expression and localization between cultured cells and human skin vesicles.
P2860
Q24683811-A437B350-1F2E-4F52-90D1-3A750BE60A94Q34518058-EE3491B4-FF34-4FE3-874F-BDCEAD8B0938Q34701202-4B69E084-20FF-495E-BBB7-93F54AD8349EQ35101416-B2A37BB7-F766-4DFA-BD9D-0858BBE18807Q35841513-4A5AE2A0-DE28-4A4C-BEE2-4AB2A5D5EE4AQ36380849-26AB7C22-F279-4380-83FC-3DEDA533C236Q36656146-96DAE695-B8CA-496C-B787-C725E82CA9CDQ36698176-2DC8ACB2-518A-475C-9413-E964C9F9501BQ36798650-F074074D-8159-43C4-A8A1-9AE4AA32F9BBQ36969576-047EFFC6-B298-42A5-BD28-763C88EEE215Q39589384-410C6B08-4700-4DDC-B417-A3D0F35840B1Q40007098-70C90D3E-4885-4F92-A5CF-B09B48A1E0D4Q42415994-D237F0C5-95ED-46DD-AC9E-C9AEDB3B25EEQ42573780-05C636B2-7D01-4E5D-B3C3-A7A54E8B0516
P2860
The glycoprotein products of varicella-zoster virus gene 14 and their defective accumulation in a vaccine strain (Oka).
description
1990 nî lūn-bûn
@nan
1990年の論文
@ja
1990年論文
@yue
1990年論文
@zh-hant
1990年論文
@zh-hk
1990年論文
@zh-mo
1990年論文
@zh-tw
1990年论文
@wuu
1990年论文
@zh
1990年论文
@zh-cn
name
The glycoprotein products of v ...... ion in a vaccine strain (Oka).
@en
type
label
The glycoprotein products of v ...... ion in a vaccine strain (Oka).
@en
prefLabel
The glycoprotein products of v ...... ion in a vaccine strain (Oka).
@en
P2093
P2860
P1433
P1476
The glycoprotein products of v ...... ion in a vaccine strain (Oka).
@en
P2093
P2860
P304
P407
P577
1990-09-01T00:00:00Z